Advisory Committee

Co-Conveners

• Edward Abrahams, Ph.D.
  President
  Personalized Medicine Coalition
• Margaret Foti, Ph.D., M.D. (h.c.)
  Chief Executive Officer
  American Association for Cancer Research
• Marcia A. Kean, M.B.A.
  Chairman, Strategic Initiatives
  Feinstein Kean Healthcare

Advisory Committee Members

• Amy Abernethy, M.D., Ph.D.
  Chief Medical Officer, Chief Scientific Officer, Vice President, Oncology
  Flatiron Health, Inc.
• Anna Barker, Ph.D.
  Professor and Director, Transformative Healthcare Networks
  Co-Director, Complex Adaptive Systems Initiative
  Arizona State University
• Ken Buetow, Ph.D.
  Director of Computational Sciences and Informatics
  Complex Adaptive Systems Initiative
  Arizona State University
• Randy Burkholder
  Vice President
  Pharmaceutical Research and Manufacturers of America (PhRMA)
• William S. Dalton, Ph.D., M.D.
  Founder and Chief Executive Officer, M2Gen
  Director, DeBartolo Family Personalized Medicine Institute
  Moffitt Cancer Center
• Patricia J. Goldsmith
  Chief Executive Officer
  CancerCare
• Linda House, R.N., B.S.N., M.S.M.
  President
  Cancer Support Community
• Zeba Khan, Ph.D.
  Vice President of Global Strategic Market Access & Policy
  Celgene Corporation
• Raju Kucherlapati, Ph.D.
  Paul C. Cabot Professor of Genetics
  Harvard Medical School
• J. Leonard Lichtenfeld, M.D., MACP
  Deputy Chief Medical Officer
  American Cancer Society
• Gilbert Omenn, M.D., Ph.D.
  Chair, American Association for Cancer Research Health Policy Subcommittee
  Professor of Computational Medicine & Bioinformatics, University of Michigan
• Richard L. Schilsky, M.D., FACP, FASCO
  Senior Vice President and Chief Medical Officer
  American Society of Clinical Oncology
• Laura van't Veer, Ph.D.
  Leader, Breast Oncology Program
  Director, Applied Genomics
  UCSF Helen Diller Family Comprehensive Cancer Center